Literature DB >> 9256956

Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir.

G Pialoux, S Fournier, A Moulignier, J D Poveda, F Clavel, B Dupont.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9256956     DOI： 10.1097/00002030-199710001-00009

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  18 in total

1.  Lopinavir measurement in pleural effusion in a human immunodeficiency virus type 1-infected patient with kaposi's sarcoma.

Authors:  Marta Boffito; Patrick G Hoggard; David J Back; Stefano Bonora; Agostino Maiello; Anna Lucchini; Giovanni Di Perri
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

2.  Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain.

Authors:  C G Filippi; A M Ulug; E Ryan; S J Ferrando; W van Gorp
Journal:  AJNR Am J Neuroradiol       Date:  2001-02       Impact factor: 3.825

3.  Comparison of human immunodeficiency virus type 1 RNA sequence heterogeneity in cerebrospinal fluid and plasma.

Authors:  Y W Tang; J T Huong; R M Lloyd; P Spearman; D W Haas
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

4.  Development of indinavir submicron lipid emulsions loaded with lipoamino acids-in vivo pharmacokinetics and brain-specific delivery.

Authors:  Swetha Bollam; Prabhakar Kandadi; Shashank Sridhar Apte; Kishan Veerabrahma
Journal:  AAPS PharmSciTech       Date:  2011-03-01       Impact factor: 3.246

5.  Global gray and white matter metabolic changes after simian immunodeficiency virus infection in CD8-depleted rhesus macaques: proton MRS imaging at 3 T.

Authors:  William E Wu; Assaf Tal; Ivan I Kirov; Henry Rusinek; Daniel Charytonowicz; James S Babb; Eva-Maria Ratai; R Gilberto Gonzalez; Oded Gonen
Journal:  NMR Biomed       Date:  2013-02-17       Impact factor: 4.044

6.  Persistent SIV infection of a blood-brain barrier model.

Authors:  Lisa Strelow; Damir Janigro; Jay A Nelson
Journal:  J Neurovirol       Date:  2002-08       Impact factor: 2.643

7.  Discordant genotypic resistance and HIV-1 genetic diversity from paired plasma and cerebrospinal fluid samples in Chinese settings.

Authors:  Lifeng Liu; Yulin Zhang; Feili Wei; Qingxia Zhao; Xicheng Wang; Lin Yuan; Ning Li; Dexi Chen
Journal:  J Neurovirol       Date:  2013-01-17       Impact factor: 2.643

8.  Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment.

Authors:  Theresa K Smit; Bruce J Brew; Wallace Tourtellotte; Susan Morgello; Benjamin B Gelman; Nitin K Saksena
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 9.  Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review.

Authors:  Lucette A Cysique; Bruce J Brew
Journal:  Neuropsychol Rev       Date:  2009-05-09       Impact factor: 7.444

10.  Genetic shift of env V3 loop viral sequences in patients with HIV-associated neurocognitive disorder during antiretroviral therapy.

Authors:  Christian Eggers; Oliver Müller; Ingo Thordsen; Michael Schreiber; Axel Methner
Journal:  J Neurovirol       Date:  2013-10-08       Impact factor: 2.643
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.